ABBLO PHARMA ApS: Financial statements 2013
CVR: 34080534
Source: annual report 2013, Danish Business Authority
01/10/2012 – 30/09/2013
ABBLO PHARMA ApS (CVR 34080534) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -11,750 and a net result of DKK -2,697,303. Equity in the 2013 report amounted to DKK -2,215,218.
- Gross Profit
- DKK -11,750
- Profit/Loss
- DKK -2,697,303
- Equity
- DKK -2,215,218
- Total Assets
- DKK 4,182,342
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
ABBLO PHARMA ApS has published its interim report for the period December 13, 2011 – September 30, 2012.
About ABBLO PHARMA ApS
ABBLO PHARMA ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2011. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Nic Borch-Christensen and Mie Hjerrild Petersen. The board consists of Mie Hjerrild Petersen (chair) and Nic Borch-Christensen. The company is owned by ABBLO S.à.r.l. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 471,866 and a net result of DKK -152,259 compared with DKK 135,215 the year before. Equity in the 2025 report amounted to DKK -238,088.